1. What Is the Continuous Glucose Monitor Market?
The Continuous Glucose Monitor Market covers wearable sensors that measure glucose concentration continuously through the interstitial fluid, supplying real-time and trend data to patients and clinicians managing diabetes without the need for frequent fingerstick blood tests. Diabetic patients use continuous glucose monitors to track glucose patterns, receive high and low alerts, and in closed-loop systems, automate insulin delivery. The market serves people with Type 1 and Type 2 diabetes, with Type 1 patients the primary adopters and Type 2 patients on insulin a growing secondary market. It includes the wearable sensor applied to the skin, the transmitter, and the display or smartphone application, with demand driven by clinical evidence of improved glycaemic control, expanding reimbursement, and the integration with automated insulin delivery.
2. Continuous Glucose Monitor Market Size & Forecast
3. Emerging Technologies
- Closed-loop automated insulin delivery integrating continuous glucose data with insulin pump adjustment for artificial pancreas function.
- Extended-wear sensors lasting 14 days or longer reducing the sensor change burden for patients.
- Non-adjunctive labelling eliminating the need for fingerstick confirmation for insulin dosing decisions.
- Integration with smartphone alerts and cloud-based data platforms for clinician monitoring.
Such innovations are driving change across adjacent industries too. Discover more in our Point Of Care Diagnostics Market.
4. Key Market Opportunity
The largest near-term opportunity in the Continuous Glucose Monitor market lies in type 1 patients adopting closed-loop systems for automated glycaemic management with reduced burden and improved outcomes. A second, faster-growing opportunity lies in type 2 patients on insulin gaining access through reimbursement expansion for real-time glucose trend monitoring. As adoption broadens, the addressable opportunity is expanding from early deployments toward wider commercial use, with Europe positioned for the most rapid growth through 2034.
5. Top Companies in the Continuous Glucose Monitor Market
The following organisations hold leading positions in the Continuous Glucose Monitor Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Dexcom
- Abbott (FreeStyle Libre)
- Medtronic
- Senseonics
- Insulet (Omnipod)
- Tandem Diabetes Care
- GlySens
- Biolinq
- Nemaura Medical
- Eversense
6. Market Segmentation
The Continuous Glucose Monitor Market is analysed across 4 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Patient Type | Type 1 Type 2 on Insulin Type 2 Non-Insulin |
| By Integration | Standalone CGM Closed-Loop Automated Insulin Delivery |
| By Sensor Wear Duration | 7-Day 10-Day 14-Day |
| By Geography | North America The U.S. Canada Europe The UK Germany France Italy Spain Denmark Netherlands Finland Sweden Norway Russia Austria Poland Rest of Europe Asia Pacific China Japan India South Korea Australia Indonesia Vietnam Philippines Singapore Taiwan Thailand Rest of Asia Pacific Latin America Brazil Mexico Argentina Rest of South America Middle East and Africa GCC Countries Israel South Africa Rest of Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Continuous Glucose Monitor Market trajectory over the forecast period:
Automated Insulin Delivery Systems That Integrate Continuous Glucose Monitoring.Automated insulin delivery systems that integrate continuous glucose monitoring with insulin pumps in a closed-loop system have transformed Type 1 diabetes management. The artificial pancreas algorithm adjusts insulin delivery based on real-time sensor glucose, reducing hyperglycaemia and hypoglycaemia compared with patient-managed injections. Tandem Diabetes Care, Insulet, and Medtronic supply hybrid closed-loop systems. The clinical evidence for improved time-in-range and reduced adverse events is driving adoption among motivated Type 1 patients and their healthcare teams. This closed-loop integration raises continuous glucose monitor value from a standalone sensor to a system component.
Reimbursement Expansion for Type 2 Diabetes Has Opened a Much Larger Addressable Market.Reimbursement expansion for Type 2 diabetes has opened a much larger addressable market, as payers in the United States and several European countries have expanded coverage to insulin-treated Type 2 patients. The US Medicare coverage of continuous glucose monitoring for non-insulin Type 2 patients added a very large reimbursable population. Dexcom G7 and Abbott FreeStyle Libre have demonstrated value in Type 2 management for time-in-range improvement. This reimbursement expansion is the primary near-term market expansion driver.
Sensor Wear Duration Extension Reduces the Burden of Sensor Changes.Sensor wear duration extension reduces the burden of sensor changes, as 14-day and extended-wear sensors require fewer replacement visits than 7-day predecessors. The convenience improvement supports adherence in the Type 2 population that requires less intensive management.
For related market intelligence, see the In Vitro Diagnostics Market.
8. Segmental Analysis
By patient type, the Type 1 segment dominated the Continuous Glucose Monitor Market in 2025, as insulin-dependent Type 1 patients have the highest clinical need and broadest reimbursement for continuous glucose monitoring.
By integration, the closed-loop automated insulin delivery segment is projected to register the highest CAGR in the Continuous Glucose Monitor Market through 2034, as artificial pancreas adoption grows in the Type 1 population, driving the fastest-growing integration category within the market.
9. Regional Analysis
Regional demand patterns across the Continuous Glucose Monitor Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the Continuous Glucose Monitor Market in 2025, accounting for the largest share of revenue. Moreover, the United States leads through the highest Type 1 continuous glucose monitoring adoption, the most advanced closed-loop system penetration, and the broadest reimbursement coverage including Medicare expansion. In addition, Dexcom and Abbott concentrate high-value domestic sales with premium sensor pricing. This combination of adoption, closed-loop ecosystem, and reimbursement breadth anchors revenue leadership.
Highest CAGR Region
Europe is projected to register the highest CAGR in the Continuous Glucose Monitor Market through 2034. The primary driver is national healthcare system reimbursement expansion for continuous glucose monitoring across Type 2 insulin-treated populations in Germany, France, and the United Kingdom, representing large new reimbursable populations. Moreover, European adoption of closed-loop systems is growing in Type 1 programmes. The combination of these demand drivers and an expanding base positions Europe for sustained growth outperformance through 2034.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Continuous Glucose Monitor Market was valued at USD 8.47 Bn in 2025 and is projected to reach USD 52.25 Bn by 2034, growing at a CAGR of 22.4% over the 2026–2034 forecast period.
The Continuous Glucose Monitor Market is projected to grow at a CAGR of 22.4% from 2026 to 2034.
North America dominated the Continuous Glucose Monitor Market in 2025, accounting for the largest share of revenue.
The leading companies in the Continuous Glucose Monitor Market include Dexcom, Abbott (FreeStyle Libre), Medtronic, Senseonics, Insulet (Omnipod), Tandem Diabetes Care, GlySens, Biolinq, Nemaura Medical, Eversense.
Automated insulin delivery systems that integrate continuous glucose monitoring.
By patient type, the Type 1 segment dominated the Continuous Glucose Monitor Market in 2025, as insulin-dependent Type 1 patients have the highest clinical need and broadest reimbursement for continuous glucose monitoring.
How to Order
Choose Your Package
Condensed edition of this study for students, researchers and academic institutions.
- Condensed edition of the full study
- For students, researchers & academic institutions
- Valid student ID or institutional email required
- Educational, non-commercial use only
The competitive landscape, including key market participants, company size, market positioning, and comparative competitive standing.
- 15 in-depth company profiles
- Company overview
- Product and brand portfolio mapped per company
- Revenue for the last 3 FYs with key financial metrics
- Segmental revenue and regional revenue breakdown
- Market presence, key geographies & end-use industries
- Recent developments
- Key capabilities, differentiators & strategic positioning
- SWOT Analysis
- 15-company market share analysis
- 2025 market share by company
- Company revenue in USD
- Competitive quadrant positioning
- Product portfolio comparison
The complete forecast model, including every study table, is provided in clean, formula-ready Excel format across 3 segmentation axes. Select the geographic coverage required for your analysis.
- One country, broken out across 3 segmentation axes
- 2025 base year, 2026–2034 forecast, CAGR per line
- Excel workbook
- Region totals plus every country inside that region
- All axes, all years, CAGR per line
- Cross-country comparison sheet included
- Excel workbook
- Every forecast table in the study
- Global, regional and country views in one workbook
- Segment share and CAGR pivots included
- Excel workbook
The full syndicated study. Every chapter, every region, every country, plus the complete Excel model, methodology and appendix.
- Executive summary, market scope & segmental snapshot
- Market dynamics: drivers, restraints, opportunities, challenges
- Quantitative analysis across 3 segmentation axes
- Regional analysis
- Competitive landscape, market share & company revenue mapping
- Includes the full Global Excel Data Pack
- Complete research methodology, assumptions & appendix
TAM/SAM/SOM sizing, M&A target screening, patent & IP analysis, supply-chain resilience mapping, ESG roadmaps and other bespoke strategic work.
- TAM / SAM / SOM sizing
- M&A target screening
- Patent & IP analysis
- Supply-chain resilience mapping
- ESG roadmaps & other bespoke strategic work
Not sure which package fits? Tell us the decision you are making and an analyst will recommend the smallest package that answers it. Talk to an analyst.
Ordering Process
Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.